계명대학교 의학도서관 Repository

Effect of urea cream on sorafenib-associated hand-foot skin reaction in patients with hepatocellular carcinoma: A multicenter, randomised, double-blind controlled study

Metadata Downloads
Author(s)
Young-Sun LeeYoung K. JungJi H. KimSung B. ChoDo Y. KimMoon Y. KimHyung J. KimYeon S. SeoKi T. YoonYoung M. HongJeong-Hoon LeeHyun W. LeeHyung J. YimByoung K. JangEun S. JangJae Y. JangSang Y. Hwang
Keimyung Author(s)
Jang, Byoung Kuk
Department
Dept. of Internal Medicine (내과학)
Journal Title
European Journal of Cancer
Issued Date
2020
Volume
140
Keyword
HepatocellularcarcinomaHandefoot skinreactionUrea cream
Abstract
Background:
Hand–foot skin reaction (HFSR) is the most common adverse event during sorafenib treatment in patients with hepatocellular carcinoma (HCC). In the present study, we aimed to investigate the role of urea cream in the prevention of HFSR or amelioration of HFSR severity.

Patients and methods:
Patients with HCC were treated with either placebo cream or urea cream for 12 weeks concomitantly with sorafenib treatment. HFSR development, the Hand–Foot Skin Reaction and Quality of Life (HF-QoL) questionnaire score, and adverse events were assessed at 2, 4, 8 and 12 weeks.

Results:
Of the 288 patients, 247 patients, with 117 patients in the placebo control group and 130 patients in the urea cream group, were analysed. The urea cream group showed a trend towards a lower cumulative incidence of any-grade HFSR (log-rank, P = 0.247) and severe HFSR of grade II or higher (log-rank, P = 0.394) without statistical significance. In the incidence by time point, the incidence of severe HFSR of grade II or higher was significantly lower in the urea cream group than in the placebo control group at 2 weeks (13.8% versus 23.9%, P = 0.042). The urea cream group showed a significantly better HF-QoL questionnaire score than the placebo control group (11.8 versus 19.7, P = 0.014) at 12 weeks.

Conclusions:
Treatment with urea cream showed a lower incidence of severe sorafenib-induced HFSR at 2 weeks and reduced the tendency of HFSR development in HCC patients. Therefore, treatment with urea cream may be considered for prophylaxis or improvement of HFSR grade in HCC patients treated with sorafenib.

Trial registration:
ClinicalTrials.gov (NCT03212625).
Keimyung Author(s)(Kor)
장병국
Publisher
School of Medicine (의과대학)
Citation
Young-Sun Lee et al. (2020). Effect of urea cream on sorafenib-associated hand-foot skin reaction in patients with hepatocellular carcinoma: A multicenter, randomised, double-blind controlled study. European Journal of Cancer, 140, 19–27. doi: 10.1016/j.ejca.2020.09.012
Type
Article
ISSN
1879-0852
Source
https://www.clinicalkey.com/#!/content/playContent/1-s2.0-S0959804920305189
DOI
10.1016/j.ejca.2020.09.012
URI
https://kumel.medlib.dsmc.or.kr/handle/2015.oak/43066
Appears in Collections:
1. School of Medicine (의과대학) > Dept. of Internal Medicine (내과학)
공개 및 라이선스
  • 공개 구분공개
  • 엠바고Forever
파일 목록

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.